Pacira Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Pacira Pharmaceuticals (PCRX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Pacira Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Pacira Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Pacira Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $22M | 855k | 25.77 |
| 2025-06-30 | $25M | 1.0M | 23.90 |
| 2025-03-31 | $11M | 422k | 24.85 |
| 2024-12-31 | $26M | 1.4M | 18.84 |
| 2024-09-30 | $2.9M | 191k | 15.05 |
| 2024-06-30 | $1.9M | 66k | 28.61 |
| 2024-03-31 | $4.8M | 166k | 29.22 |
| 2023-12-31 | $4.2M | 126k | 33.74 |
| 2023-09-30 | $1.7M | 56k | 30.68 |
| 2023-06-30 | $975k | 24k | 40.00 |
| 2023-03-31 | $1.2M | 30k | 40.81 |
| 2022-12-31 | $1.1M | 27k | 38.61 |
| 2022-09-30 | $1.1M | 21k | 54.55 |
| 2022-06-30 | $1.3M | 22k | 58.29 |
| 2022-03-31 | $1.6M | 22k | 76.30 |
| 2021-12-31 | $1.4M | 24k | 60.17 |
| 2021-09-30 | $1.4M | 25k | 56.02 |
| 2021-06-30 | $2.2M | 36k | 60.67 |
| 2021-03-31 | $3.4M | 48k | 70.09 |
| 2020-12-31 | $3.7M | 61k | 59.84 |
| 2020-09-30 | $1.5M | 25k | 60.10 |
| 2020-06-30 | $2.0M | 38k | 52.49 |
| 2020-03-31 | $1.6M | 47k | 33.53 |
| 2019-12-31 | $3.4M | 75k | 45.31 |
| 2019-09-30 | $679k | 18k | 38.06 |
| 2019-06-30 | $815k | 19k | 43.49 |
| 2019-03-31 | $628k | 17k | 38.09 |
| 2018-12-31 | $309k | 7.2k | 42.82 |
| 2018-09-30 | $410k | 8.4k | 49.01 |
| 2018-06-30 | $248k | 7.8k | 31.99 |
| 2018-03-31 | $1.1M | 34k | 31.82 |
| 2017-12-31 | $1.2M | 26k | 45.89 |
| 2017-09-30 | $899k | 24k | 37.56 |
| 2017-06-30 | $849k | 18k | 47.69 |
| 2017-03-31 | $660k | 15k | 45.57 |
| 2016-12-31 | $238k | 7.4k | 32.29 |
| 2016-09-30 | $170k | 5.0k | 34.25 |
| 2016-06-30 | $181k | 5.4k | 33.75 |
| 2016-03-31 | $309k | 5.8k | 53.33 |
| 2015-12-31 | $483k | 6.3k | 76.81 |
| 2015-09-30 | $244k | 5.9k | 41.01 |
| 2015-03-31 | $1.2M | 13k | 88.33 |